RGC

Regencell Bioscience Holdings Limited

HealthcareDrug Manufacturers - Specialty & GenericHKUSDCountry macro →

$23.15

LiveJun 02, 2026

Market cap

$11.45B

52w range

9.39 – 83.60

P / E

—

EPS

—

Volume

77.33K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Regencell Bioscience Holdings Limited’s valuation

No ESG data on file

ESG disclosures for RGC aren't available yet — check back shortly.

Browse the cross-market ESG hub instead.